Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: January 1, 2020; Last Reviewed: August 1, 2019
|Basgoz, Nesli||Harvard Medical School||Allergen||Equity Interest|
|Chomel, Bruno||University of California Davis||None||N/A|
|Kirby, James||Harvard Medical School||None||N/A|
|Koehler, Jane*||University of California San Francisco||UpToDate||Reviewer|
|Rose, Stacey*||Baylor College of Medicine||None||N/A|
|* Group lead
Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive